Identification of Genomic Predictors of Adverse Events After Cardiac Surgery (CABGGenomics)
Sponsor: Brigham and Women's Hospital
A observational or N/A phase clinical study on Atrial Fibrillation and Genetic Predisposition to Disease, this trial is actively recruiting participants. The trial is conducted by Brigham and Women's Hospital and has accumulated 16 data snapshots since 2000. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
-
Oct 2018 — Feb 2020 [monthly]
Recruiting
-
Aug 2018 — Oct 2018 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Aug 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Johns Hopkins University
- National Heart, Lung, and Blood Institute (NHLBI)
- Texas Heart Institute
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .